Genmab
GMAB
GMAB
193 hedge funds and large institutions have $1.43B invested in Genmab in 2022 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 79 increasing their positions, 60 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
7% more funds holding
Funds holding: 180 → 193 (+13)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
193
Holding in Top 10
2
Calls
$7.94M
Puts
–
Top Buyers
| 1 | +$186M | |
| 2 | +$41.5M | |
| 3 | +$30.6M | |
| 4 |
CCM
CAAS Capital Management
New York
|
+$11.2M |
| 5 |
Goldman Sachs
New York
|
+$7.34M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$9.03M | |
| 3 | -$5.62M | |
| 4 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
-$4.39M |
| 5 |
HJGA
Hardman Johnston Global Advisors
Stamford,
Connecticut
|
-$2.85M |